PeptideStack
5.2kquestions
20kanswers
220users

Does AST tell me anything about hepatic fat on semaglutide?

Asked 25 Apr 2025Modified 11 months agoViewed 13k times
13

The case in front of me: AST · semaglutide.

I would like the mechanism, because I want to be able to reason about the cases nobody has written about.

I have tried to reason it out from first principles and got to two contradictory conclusions.

What is actually going on here, physically?

liver-enzymes
liver-enzymes

ALT, AST, GGT and ALP: what they do and do not indicate about hepatic fat, why enzymes are a poor surrogate for histology, and where non-invasive…

91 questions
mash
mash

Metabolic dysfunction-associated steatohepatitis: histological endpoints, resolution without worsening fibrosis, fibrosis improvement by stage,…

56 questions
bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
semaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

470 questions
shareeditfollowflag
RO
askedrae_oyelowo17k2825 Apr 2025
Do you have a baseline from before you started, or is this the first panel? – Dr_Fatima_Belkacem 4 months ago
add a comment

5 Answers

Accepted answer first, then by votes
44

Accepted answer

The short version: enzymes in this class usually fall as weight falls, and a rise is a reason to look for a cause rather than to assume a drug effect.

Alanine aminotransferase is relatively liver-specific; aspartate aminotransferase is also present in muscle, heart and red cells. A raised AST with a normal ALT after heavy resistance training is usually muscle, and creatine kinase settles the question.

Weight loss of ten per cent or more typically reduces transaminases substantially in people whose elevation was driven by hepatic fat, which is the majority of mild elevations in this population.

Hy's law and its variants are the standard framework for identifying drug-induced liver injury in trials and are why bilirubin is measured alongside transaminases rather than instead.

The caveat is direct: rising liver enzymes with jaundice, dark urine or right-upper-quadrant pain is a same-day clinical problem, not a forum question.

New training, alcohol and over-the-counter products first. Then the interesting hypotheses.

shareimprove this answerflag
DV
answered · acceptedDr_Bram_Verhoeven84k24812 Aug 2025
Small correction: eGFR is an estimate derived from creatinine, not a measurement, and the equation used matters. – tandem_gradient 6 months ago
add a comment
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
53

The relevant detail is that reference intervals for alanine aminotransferase differ between laboratories and have been revised downward over time, so the same value can be normal on one report and elevated on another.

Hy's law describes the combination that matters: transaminases above three times the upper limit together with bilirubin above twice the upper limit and no cholestatic explanation. That combination is a signal; isolated mild transaminase elevation is not.

Creatine kinase, alkaline phosphatase and bilirubin together tell you which compartment the abnormality is in, and ordering the transaminases alone throws that information away.

Laboratory-specific reference intervals for transaminases vary enough that cross-laboratory comparison of borderline values is unreliable.

Transaminases plus bilirubin plus alkaline phosphatase, or you have not measured enough to conclude anything.

edited 17 May 2025 by claudia_ferrante — corrected a unit error in the worked example

shareimprove this answerflag
CF
answeredclaudia_ferrante22k276 May 2025
36

Worth being precise here: this is one of the areas where the trend across several measurements is far more informative than any single result.

Very rapid weight loss can transiently worsen liver biochemistry, which is one of several arguments against pursuing the steepest possible trajectory.

Stated carefully, gamma-glutamyl transferase is sensitive and unspecific: it rises with alcohol, with several medications and with fatty liver, and an isolated elevation rarely changes anything on its own.

Get a baseline before you start anything, because it converts an uninterpretable result into an interpretable one for the cost of one blood draw.

shareimprove this answerflag
DV
answeredDr_Bram_Verhoeven84k24823 Aug 2025
21

The honest answer is that mild elevation is very common, that it usually improves with weight loss, and that the exceptions are the reason anyone checks.

Reference upper limits around forty units per litre for ALT are conventional rather than physiological; several groups have argued for limits closer to thirty for men and twenty-five for women.

Read the pattern before the magnitude, and the magnitude in multiples of the upper limit.

shareimprove this answerflag
DV
answeredDr_Ilse_Vandenberg113k2481 Aug 2025
5Any view on cystatin C where muscle mass is falling? Creatinine seems to mislead in exactly that case. – petra_hovland 10 months ago
6Does this hold for a non-fasting draw, or does the triglyceride figure make that a different conversation? – RP_C18 43 days ago
add a comment
16

Answering this needs the magnitude in multiples of the upper reference limit, because the thresholds that matter clinically are defined that way and not in absolute units.

An isolated result three weeks after starting anything is difficult to interpret. A baseline taken before starting makes the same result trivially interpretable, which is the argument for baselines.

Isolated mild elevation is common and usually improves with weight loss.

shareimprove this answerflag
ID
answeredimani_dube8.9k1520 Jun 2025
Thank you — this is the answer I was looking for. – bac_or_bust 2 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.